Apex on stronger footing; expands pharmaceutical, consumer products


CEO of Apex Healthcare Bhd, Dr Kee Kirk Chin. - Art Chen/ The Star, 10 June 2014.

PETALING JAYA: Apex Healthcare Bhd’s transformation into a healthcare group from a pharmaceutical-based company has put it on a stronger footing in terms of revenue and earnings.

Chairman and chief executive officer Dr Kee Kirk Chin says Apex’s objective is to be an important regional player by growing the pharmaceutical, consumer products and orthopaedics business and increasing its exports.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Corporate News , Apex Pharmacy , earnings , 7090 ,

   

Next In Business News

Asian FX subdued after mixed US data; equities set for weekly gains
Global manufacturing activity recovery to continue gradually into 2024 - S&P Global
Country Garden plans to present debt revamp plan in second half, sources say
Oil prices on track to snap two-week losing streak
MAA Group sells entire 58% stake in Turiya for RM52.86mil
Majuperak, Shizen to explore solar photovoltaic development in Perak
Asia stocks rise, yen plumbs 34-year low as BOJ stands pat on rates
Fernandes: AirAsia Group to be listed on Bursa Malaysia in September
Spritzer clarifies mistaken identity in insider trading report
Berjaya Corp denies involvement in Forest City Casino talks

Others Also Read